RNA inverse folding on CASP15 (test)
58.88Sequence RecoverySOLD
Evaluation results
| Method | Links | ||||||
|---|---|---|---|---|---|---|---|
| SOLD2026.01 | 58.88 | -64.0375 | 69.57 | 26.8422 | 36.8 | — | |
| LDM2026.01 | 54.62 | -52.7387 | 55.43 | 29.7038 | 32.37 | — | |
| LDMRL Fine-tuning=false2026.01 | 54.62 | — | — | — | — | 54.73 | |
| RiboDiffusion2026.01 | 53.88 | -41.1593 | 46.99 | 29.5904 | 32.1 | — | |
| RiboDiffusion2026.01 | 53.88 | — | — | — | — | 38.71 | |
| gRNAde2026.01 | 50.97 | -40.8491 | 41.86 | 30.8809 | 31.21 | — | |
| gRNAde2026.01 | 50.97 | — | — | — | — | 51.49 | |
| DRAKES2026.01 | 34.84 | -61.0354 | 64.12 | 27.1322 | 35.87 | — | |
| DRAKES-PretrainRL Fine-tuning=false2026.01 | 33.57 | — | — | — | — | 33.74 | |
| RDesign2026.01 | 32.64 | -37.0679 | 42.39 | 30.0221 | 31.65 | — | |
| RDesign2026.01 | 32.64 | — | — | — | — | 32.51 | |
| RhoDesign2026.01 | 26.06 | -45.962 | 47.08 | 30.2765 | 33.06 | — | |
| RhoDesign2026.01 | 26.06 | — | — | — | — | 25.75 | |
| DDPOTraining Objective=MFE2026.01 | — | -63.9567 | — | — | — | — | |
| DDPOTraining Objective=SS2026.01 | — | — | 66.49 | — | — | — | |
| DDPOTraining Objective=LDDT2026.01 | — | — | — | — | 34.06 | — | |
| DPOKTraining Objective=MFE2026.01 | — | -67.7949 | — | — | — | — | |
| DPOKTraining Objective=SS2026.01 | — | — | 63.03 | — | — | — | |
| DPOKTraining Objective=LDDT2026.01 | — | — | — | — | 33.51 | — | |
| DRAKESTraining Objective=MFE2026.01 | — | -61.0354 | — | — | — | — | |
| DRAKES-PretrainTraining Objective=MFE2026.01 | — | -52.6827 | — | — | — | — | |
| LDMTraining Objective=MFE2026.01 | — | -52.7387 | — | — | — | — | |
| LDMTraining Objective=SS2026.01 | — | — | 55.43 | — | — | — | |
| LDMTraining Objective=LDDT2026.01 | — | — | — | — | 32.37 | — | |
| SOLDTraining Objective=MFE2026.01 | — | -68.21 | — | — | — | — | |
| SOLDTraining Objective=SS2026.01 | — | — | 70.1 | — | — | — | |
| SOLDTraining Objective=LDDT2026.01 | — | — | — | — | 35.48 | — |